Labcorp Holdings Inc.
Explore Labcorp Holdings
Core profile pages, annual revenue records, and related research hubs for this company.
Leadership History
4 leaders · Full leadership timeline
Labcorp is a healthcare infrastructure company: most patients never think about it, but test results shape diagnoses, treatment decisions, clinical trials, and insurance workflows every day.
Labcorp makes money from diagnostic testing ordered by physicians, hospitals, employers, payers, and patients, plus biopharma laboratory services such as central lab work, early development, companion diagnostics, and clinical-trial support. Volume, reimbursement rates, test mix, logistics efficiency, and laboratory automation drive profitability.
Chairman and Chief Executive Officer
Schechter has led Labcorp through the Fortrea spin-off, specialty testing expansion, and health-system partnership strategy.
Executive Vice President and Chief Financial Officer
Wang oversees financial strategy, capital allocation, productivity programs, and investor communication.
Former Chairman and CEO
King led the Covance acquisition and expanded Labcorp beyond routine diagnostics into drug-development services.
National Health Laboratories founder era
The National Health Laboratories legacy helped shape the modern independent lab platform that became Labcorp.
Labcorp faces Medicare and commercial reimbursement pressure, competition from Quest Diagnostics and hospital labs, labor availability, cybersecurity and privacy risk, and integration complexity from health-system partnerships and acquisitions. The company also has to keep expanding specialty testing without weakening routine-test efficiency.
Adam H. Schechter is CEO of Labcorp.
Leadership is focused on execution, profitability, customer value, and long-term strategic positioning.
Leadership changes explain shifts in capital allocation, risk appetite, and operating priorities.
Labcorp's leaders have shaped its operating model, growth choices, and response to industry change.